Guides
Cosmetic regulatory guides.
Plain explainers on selling cosmetics across the EU, UK, Switzerland and the United States.
Cross-border cosmetic regulation is complex, and good information is hard to find. These guides set out, market by market, what the law requires and what a brand has to do to comply. They are written as practical references for founders and teams planning to expand. If you would rather hand the whole thing over, that is what CIG does.
Each of the four markets below is a separate legal regime with its own rules, its own portal, and its own paperwork. A notification in one does nothing for the others. This hub explains the shared vocabulary first, then the requirements market by market, so you can see what applies to your products before you read the detailed guide for each region.
Reference library
The guide library, organised by market.
Start with your market
The four complete market guides. Each covers the full journey from formula to shelf.
How to sell cosmetics in the EU
Responsible Person, PIF, CPSR and CPNP notification under Regulation 1223/2009.
Read the EU guide → United KingdomHow to sell cosmetics in the UK
UK Responsible Person and SCPN notification through OPSS.
Read the UK guide → SwitzerlandHow to sell cosmetics in Switzerland
Swiss-address responsible person and the ten-year file.
Read the Switzerland guide → United StatesSelling cosmetics in the US under MoCRA
Facility registration, product listing and the US Agent role.
Read the MoCRA guide →European Union
The EU machinery in depth: the notification, the Responsible Person, and the documents behind them.
The CPNP notification, explained
Who files, what goes in, nanomaterials, confidentiality and cost.
Read the CPNP guide → European UnionEU Responsible Person requirements
Who needs one, who can hold the role, and what it does.
Read the RP guide → European UnionSwitching your EU Responsible Person
The mandate, the PIF transfer, CPNP updates and the label, in order.
Read the switching guide → European UnionCPSR required inputs
The data your assessor needs, and which inputs set the timeline.
Read the inputs guide → European UnionCPSR cost and timeline
What it costs, what drives price, and why the lab sets the calendar.
Read the cost guide → European UnionThe Product Information File, explained
Article 11 contents, the ten-year rule, and PIF vs CPSR.
Read the PIF guide → European UnionCPSR vs PIF vs notification
The safety report, the dossier and the filing: side by side, in order.
Read the comparison → European UnionBanned and restricted ingredients
Retinol, kojic acid, hydroquinone and more: the actual annex entries, captured.
Read the ingredient guide → European UnionCosmetic claims rules
Natural, clean, hypoallergenic: the six criteria and the banned claims.
Read the claims guide → European UnionCruelty-free and the law
Article 18’s bans, and what the bunny logos add on top.
Read the guide → European UnionPrivate label compliance
Your name on the jar means your file: what white-label brands actually owe.
Read the guide → European UnionCosmetic testing requirements
Stability, challenge and micro: what each proves and how long it takes.
Read the testing guide → TestingMicrobiology testing
ISO methods, the pathogen panel, and the limits under ISO 17516.
Read the guide → TestingChallenge testing (PET)
ISO 11930, the 28-day protocol, and Criteria A and B.
Read the guide → TestingStability testing
Accelerated studies, PAO support, and the launch-timeline long pole.
Read the guide →United Kingdom
Great Britain's own machinery after Brexit: the SCPN and the UK Responsible Person.
The SCPN notification, explained
Who files through OPSS, Northern Ireland, and how it differs from CPNP.
Read the SCPN guide → United KingdomUK Responsible Person requirements
Who needs one after Brexit, GB labels and Northern Ireland.
Read the UK RP guide → United KingdomSwitching your UK Responsible Person
The GB handover: mandate, SCPN updates and the label transition.
Read the switching guide →Switzerland
Nothing is filed. You keep an inspection-ready dossier at a Swiss address.
United States
MoCRA's duties in detail: renewals, listings, and who is exempt.
MoCRA renewals, explained
How biennial facility-registration renewals work and how to check your date.
Read the deadline briefing → United StatesThe MoCRA small-business exemption
The $1M threshold, the categories that void it, and what still applies.
Read the exemption guide → United StatesMoCRA product listing
Who files, the 120-day window, and how Cosmetics Direct works.
Read the listing guide →Comparisons & multi-market
Cross-border questions: how the regimes differ and what every market wants on the pack.
The evidence library
Highlighted captures of the actual legal texts our guides cite, with source stamps.
Browse the evidence → ComparisonUS vs EU
Registration and honesty vs pre-market proof: the Atlantic divide, mapped.
Read the comparison → Multi-marketWhat compliance actually costs
Published numbers for the EU, UK, US and Switzerland, per product.
Read the cost guide → ComparisonEU vs UK after Brexit
Two Responsible Persons, two portals, and the Northern Ireland wrinkle.
Read the comparison → Multi-marketLabel requirements by market
What must appear on the pack in the EU, UK, Switzerland and the US.
Read the label guide → Multi-marketSelling cosmetics on marketplaces
Why Amazon checks compliance faster than any regulator, and what the GPSR changed.
Read the marketplace guide →Start here
The words every guide uses.
Four terms come up on almost every page: Responsible Person, PIF, CPSR, and notification. Brands often treat them as one thing. They are separate steps, and each market handles them differently.
Responsible Person
The Responsible Person is the legal entity accountable for a cosmetic product on a given market. In the EU, Regulation (EC) No 1223/2009 requires every product to have a Responsible Person established in the Union. That person holds the Product Information File, verifies the safety report, files the notification, checks labelling and claims, and is the official contact for authorities, including during a recall. The role can be filled by the manufacturer, the importer, a distributor, or a third-party service provider. A non-EU brand cannot be its own EU Responsible Person, so it must appoint a third-party Responsible Person or set up its own EU entity. The Responsible Person's name and address must appear on the product label. The liability is continuous: it lasts for the whole time the product is on the market, not just at launch.
Product Information File (PIF)
The PIF is the dossier a Responsible Person keeps for each product and makes available to authorities on request. Under Article 11 of Regulation 1223/2009 it must contain: a description of the product, the Cosmetic Product Safety Report, a description of the manufacturing method with a statement of compliance with good manufacturing practice (ISO 22716), proof of the claimed effect where the nature of the claim justifies it, and data on any animal testing. The PIF must be kept for ten years after the last batch was placed on the market.
Cosmetic Product Safety Report (CPSR)
The CPSR is the signed safety assessment that sits inside the PIF. It follows Annex I of Regulation 1223/2009 and has two parts. Part A, the safety information, covers the quantitative and qualitative composition, physico-chemical characteristics and stability, microbiological quality including challenge testing, impurities and traces and packaging, normal and reasonably foreseeable use and exposure, the toxicological profile, and any undesirable effects. Part B, the safety assessment, states the conclusion, any warnings and instructions for use, the reasoning behind the assessment including the Margin of Safety, and the assessor's name, address, qualification, date, and signature. Part B can only be signed by a qualified assessor who holds a university diploma in pharmacy, toxicology, medicine, or a similar discipline recognised by an EU Member State. A safety report written for another market, such as a US report, does not transfer to the EU format, so it usually has to be redone.
Notification
Notification is the act of registering a product with the authorities before it goes on sale. Each market has its own system. The EU uses the CPNP (Cosmetic Product Notification Portal). Great Britain uses the SCPN (Submit Cosmetic Product Notification) service run by the Office for Product Safety and Standards (OPSS). The US uses FDA product listing under MoCRA. Switzerland has no pre-market notification portal at all. These systems are separate and do not share data, so notifying in one market does nothing for the others.
The four regimes
What each market requires.
The requirements below are the legal baseline for placing a cosmetic product on each market. The linked guides go deeper on process, documents, and timelines.
European Union
The EU regime runs on Regulation (EC) No 1223/2009. Every product needs a Responsible Person established in the Union, a Product Information File, a signed CPSR, and a CPNP notification. The CPNP notification is required under Article 13 before a product is placed on the EU market. Once a product is notified in CPNP, no further national-level notification is needed within the EU. Products containing nanomaterials require a separate notification under Article 16.
The CPNP portal itself is free of charge. The cost is in appointing a Responsible Person and preparing the documentation. A notification requires the product name, category and function, the Responsible Person's contact details, the full INCI formulation, images of the label and packaging, the CPSR reference and the toxicologist's details, and manufacturing country and batch information. CPNP data is made available only to competent authorities for market surveillance and to poison centres for medical treatment. Full product and formula data is not visible to competitors or the public.
Compliance is size-blind. There is no small-business exemption and no turnover threshold. A hobbyist selling a few bars of soap faces the same mandatory Responsible Person, PIF, and CPSR burden as a multinational.
United Kingdom
After Brexit, Great Britain runs its own regime, effective 1 January 2021: the retained version of Regulation 1223/2009, known as the UK Cosmetics Regulation, enforced through the Cosmetic Products Enforcement Regulations 2013. A product made available in Great Britain must have a Responsible Person established in the UK, and notification goes through the SCPN service operated by OPSS, which replaced CPNP for the Great Britain market.
A UK Responsible Person needs a genuine UK-established address. PO boxes and mail-forwarding addresses do not qualify. The UK Responsible Person keeps the PIF for ten years after the last batch, notifies OPSS before the product is made available, and reports serious undesirable effects. A brand selling into both the EU and Great Britain needs both a UK Responsible Person and a separately established EU Responsible Person. One Responsible Person cannot cover both, and CPNP and SCPN operate independently, each requiring its own notification.
Northern Ireland is treated separately from Great Britain. Under the Windsor Framework, the Northern Ireland market continues to follow EU Regulation 1223/2009, so it aligns with the EU Responsible Person and CPNP route rather than the Great Britain UK Responsible Person and SCPN route.
Switzerland
Switzerland sits under the Federal Act on Foodstuffs and Utility Articles (817.0) and its ordinance, with cosmetics governed by Ordinance 817.023.331. Article 54 requires cosmetics to comply with the annexes of EU Regulation 1223/2009 for prohibited ingredients, colourants, and preservatives, so the ingredient rules track the EU. The rest of the compliance chain is Swiss.
An EU Responsible Person does not cover Switzerland. The responsible person, whether the manufacturer, the importer, or an appointed agent, must have an address on Swiss territory, and the obligation cannot be delegated to anyone located abroad. If no Swiss responsible person is appointed, the company's CEO or equivalent legal representative becomes the responsible person by default. Switzerland has no pre-market notification portal and no access to CPNP. In-market control relies on cantonal laboratories across the 26 cantons carrying out post-market inspections, so a brand must hold a self-monitoring dossier that is ready to show on request. The PIF must be kept for ten years from the date the last batch was first placed on the market. An existing PIF compiled abroad can satisfy Swiss requirements if it complies with Swiss cosmetics and labelling rules, and it may be written in an official Swiss language or in English. Labelling warnings and instructions must appear in at least one official Swiss language: German, French, or Italian.
United States (MoCRA)
MoCRA, the Modernization of Cosmetics Regulation Act, is the federal US regime. The Responsible Person is the manufacturer, packer, or distributor whose name appears on the product label. That person must list each marketed cosmetic product with the FDA, including its ingredients, and update the listing annually. The manufacturing facility must also be registered. These are two separate obligations: the manufacturer registers the facility, and the brand named on the label does the product listing and the adverse-event reporting. Assuming a contract manufacturer handles all of it is a common and costly error.
There is no FDA fee to register a facility or list a product under section 607 of the FD&C Act. Registration and listing use FDA's free Cosmetics Direct tool, which authors submissions in the SPL (Structured Product Labeling) XML format; paper alternatives are Form FDA 5066 for registration and Form FDA 5067 for listing. An FDA Establishment Identifier (FEI) is required before submitting. Listing a product with the FDA does not mean it is FDA approved. The FDA does not approve cosmetic products before they go on the market.
MoCRA defines a small business as one whose average gross annual US cosmetic sales over the previous three-year period are under 1,000,000 US dollars. Qualifying small businesses are exempt from good manufacturing practice requirements, facility registration, and product listing. The exemption is narrow. It does not apply to products that regularly contact the mucous membrane of the eye, are injected, are intended for internal use, or alter appearance for more than 24 hours where removal is not part of customary use. A single eyeliner or eye cream can void it. Adverse-event reporting, labelling, and safety substantiation still apply to every firm, exempt or not. A serious adverse event must be reported to the FDA within 15 business days, with follow-up information within a further 15 business days.
A foreign facility that must register has to designate a US Agent who resides or maintains a place of business in the US and is physically present there. A mailbox or answering service does not qualify. The US Agent is the FDA’s communication liaison for the foreign facility, and this role is separate from being the Responsible Person. Separately, the product label must include a US contact for adverse-event reporting.
The path to compliance
What the process looks like.
The order below holds across the EU, UK, and Switzerland. The US MoCRA path is shorter, since it is registration and listing rather than a full safety dossier and portal notification.
Appoint a Responsible Person for each market. Only an entity established in the market can access its portal and be named on the label. For the EU, the UK, and Switzerland, that is a separate appointment each time.
Gather the technical data. This is the full formula with INCI names and percentages, the manufacturing details and a good manufacturing practice statement, raw-material specifications and safety data, packaging information, and any test results you already hold.
Run the required testing. Stability, challenge or preservative-efficacy testing, microbiological testing, and packaging-compatibility testing feed the safety assessment. Stability testing is usually the longest single step, which is why the whole process runs in months, not weeks. Any claim you want to make (SPF, water resistance, moisturisation, anti-aging) needs its own substantiation study.
Have the CPSR written and signed. A qualified safety assessor completes Part A and signs Part B. Without a signed Part B, the PIF is incomplete and the product cannot be placed on the EU, UK, or Swiss market.
Assemble the PIF. The safety report, product description, manufacturing method, claim substantiation, and animal-testing data go into one file the Responsible Person holds for ten years.
Notify the product. The Responsible Person files the CPNP notification for the EU, or the SCPN notification for Great Britain, before the product is placed on the market. Switzerland has no notification step, but the self-monitoring dossier must be ready for cantonal inspection.
Keep the file current. Responsible Person liability continues for as long as the product is sold. Formula changes, new claims, and new variants all update the dossier.
What goes wrong
Common mistakes that cause recalls and takedowns.
Most enforcement problems come from a short list of errors. Market-surveillance findings and first-timer failures cluster around the same causes.
An incomplete or missing PIF. A missing safety report, missing manufacturing details, or a PIF that cannot be produced on request is one of the most common findings, and it can force a product withdrawal.
Using a prohibited or restricted ingredient. An ingredient banned or restricted under the annexes of Regulation 1223/2009 is a frequent cause of recalls and Safety Gate alerts.
Labelling errors. Missing batch numbers, warnings not translated into the required language, and a missing INCI list all trigger relabelling or withdrawal.
Failing to notify. Skipping CPNP or SCPN before placing a product on the market leaves it non-compliant even if everything else is in order.
Unsubstantiated claims. Claims that cannot be backed by evidence are a recurring weakness under the Article 19 labelling rules.
Microbiological contamination. Products that fail microbiological quality, often because challenge testing was skipped, are a standing recall cause.
Making drug claims. In the US, claims such as treating eczema or reducing inflammation reclassify a product as an over-the-counter drug, taking it out of MoCRA and into stricter drug rules. This has drawn FDA warning letters.
Assuming one market covers another. Treating an EU notification as UK cover, or an EU Responsible Person as Swiss cover, leaves a product unlawfully placed in the market it was never notified in.
Selling online
What marketplaces require.
Marketplace rules now mirror the law, and in some cases enforce it faster than the authorities do.
Marketplaces such as Amazon, Etsy, and Notino now ask for proof that a Responsible Person is appointed before they will list cosmetics, which makes the appointment a commercial gatekeeper as well as a legal one. Enforcement is uneven across platforms, and that unevenness catches sellers out.
Etsy does not check for a CPSR at the point of listing, which lulls sellers into thinking they do not need one. They remain fully liable and can be asked for documentation at any time. Amazon EU actively demands the CPSR and PIF and suspends listings that do not have them. Without a valid Responsible Person, Amazon can suppress a listing so shoppers cannot see it, suspend the whole account, lock FBA inventory in the country it sits in, and goods can be seized and destroyed at customs.
GPSR adds a further layer. Since 13 December 2024, a product cannot be placed on the EU market without an EU-based economic operator, and marketplaces enforce this for third-party sellers. In Great Britain, failing to notify OPSS can carry a fine and up to three months' imprisonment, fines are unlimited in England and Wales and up to 5,000 pounds in Scotland and Northern Ireland, and OPSS and Trading Standards can prohibit sales until compliance is achieved.
Common questions
Frequently asked questions.
Plain answers to the questions brands ask most often before they expand.
In practice
Compliance, in the real world.

